Recorded fact · drug.label_indication
drug.label_indication for encorafenib|non-small-cell-lung-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact bb461e24 resolves to.
The record
| Fact id | bb461e24fc0c24719bbc4083 |
|---|---|
| Entity | drug: encorafenib|non-small-cell-lung-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260226 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Non-Small Cell Lung Cancer (NSCLC) • in combination with binimetinib, for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 577b932a734a577b2e861194ec7284305ac4047c74b7ac51271b7813d72720fb.
The value
{
"ingredient": "Encorafenib",
"conditionId": "non-small-cell-lung-cancer",
"conditionName": "Non-Small Cell Lung Cancer",
"matchedAlias": "Non-Small Cell Lung Cancer",
"context": "indication",
"brand": "BRAFTOVI",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "235dfc38-0f0b-4037-b501-7a9f4294740c",
"labelEffectiveTime": "20260226",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 12d6412c36fae790e308b75bb446212a8d98ec96b740ae41c7e652f1fdc964a3.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.